Ngā hua rapu - Neal Rosen
- E whakaatu ana i te 1 - 20 hua o te 143
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
Mutant BRAF Melanomas—Dependence and Resistance mā Poulikos I. Poulikakos, Neal Rosen
I whakaputaina 2011Revisão -
4
Towards a Unified Model of RAF Inhibitor Resistance mā David B. Solit, Neal Rosen
I whakaputaina 2014Artigo -
5
Targeted cancer therapies mā Li Yan, Neal Rosen, Carlos L. Arteaga
I whakaputaina 2011Editorial -
6
-
7
-
8
ERK Pathway Inhibitors: How Low Should We Go? mā Moriah H. Nissan, Neal Rosen, David B. Solit
I whakaputaina 2013Artigo -
9
-
10
-
11
-
12
-
13
-
14
-
15
BCR-ABL point mutants isolated from patients with imatinib mesylate–resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90... mā M. Gorre, Katharine Ellwood‐Yen, Gabriela Chiosis, Neal Rosen, Charles L. Sawyers
I whakaputaina 2002Artigo -
16
Activation of pp60c-src protein kinase activity in human colon carcinoma. mā Joseph B. Bolen, André Veillette, A M Schwartz, V DeSeau, Neal Rosen
I whakaputaina 1987Artigo -
17
Akt Forms an Intracellular Complex with Heat Shock Protein 90 (Hsp90) and Cdc37 and Is Destabilized by Inhibitors of Hsp90 Function mā Andrea Basso, David B. Solit, Gabriela Chiosis, Banabihari Giri, Philip N. Tsichlis, Neal Rosen
I whakaputaina 2002Artigo -
18
-
19
-
20
Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway mā Robin C. Muise‐Helmericks, H. Leighton Grimes, Alfonso Bellacosa, Scott Malstrom, Philip N. Tsichlis, Neal Rosen
I whakaputaina 1998Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Cancer research
Cell biology
Gene
Medicine
Cancer
Genetics
Signal transduction
Kinase
Internal medicine
Biochemistry
MAPK/ERK pathway
Chemistry
PI3K/AKT/mTOR pathway
Mutant
Mutation
Protein kinase B
Receptor
MEK inhibitor
Melanoma
Oncology
Colorectal cancer
Phosphorylation
KRAS
Breast cancer
Heat shock protein
PTEN
Protein kinase A
Tyrosine kinase
Hsp90